Bedfordshire, Luton and Milton Keynes Area Prescribing Committee
Ref: APC Bulletin 277
Bulletin Date: 01/10/20
Review Date: September 2022
Safinamide for Parkinson’s Disease – Bulletin 277
Formulary Status - BLACK
A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. DO NOT PRESCRIBE
APC Recommendations:
JPC Recommendation:
A Formulary application for Safinamide for the treatment of Parkinson’s Disease was considered at the September 2019 JPC meeting.
Following discussion, the Committee decided not to support the Formulary application for safinamide. The main concerns were the lack of head to head trials with appropriate comparators, safety issues (e.g. retinopathy) and cost/cost-effectiveness.
Please use the search box to search the whole site if you can't find what you're looking for:
